Literature DB >> 3225626

Evidence against location of the gene for facioscapulohumeral muscular dystrophy on the distal long arm of chromosome 14.

P W Lunt1, J G Noades, M Upadhyaya, M Sarfarazi, P S Harper.   

Abstract

A panel of 399 individuals from 24 kindreds with facioscapulohumeral muscular dystrophy (FSHD) has been established for genetic linkage studies. A previous suggestion of linkage on the distal long arm of chromosome 14 to the locus (IGHG) for the constant region of the heavy chain of IgG immunoglobulin was tested from serum Gm allotypes and from DNA analysis using an IGHG DNA probe. After applying an age-dependent weighting for presently unaffected but at risk individuals close linkage between the IGHG and FSHD loci was excluded.

Entities:  

Mesh：

Year:  1988        PMID： 3225626     DOI： 10.1016/0022-510x(88)90225-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


  8 in total

1.  The mapping of chromosome 4q markers in relation to facioscapulohumeral muscular dystrophy (FSHD).

Authors:  M Upadhyaya; P Lunt; M Sarfarazi; W Broadhead; J Farnham; P S Harper
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

2.  A closely linked DNA marker for facioscapulohumeral disease on chromosome 4q.

Authors:  M Upadhyaya; P W Lunt; M Sarfarazi; W Broadhead; J Daniels; M Owen; P S Harper
Journal:  J Med Genet       Date:  1991-10       Impact factor: 6.318

3.  A genetic linkage study of facioscapulohumeral (Landouzy-Déjérine) disease with 24 polymorphic DNA probes.

Authors:  M Upadhyaya; M Sarfarazi; P W Lunt; W Broadhead; P S Harper
Journal:  J Med Genet       Date:  1989-08       Impact factor: 6.318

4.  Linkage analysis in the spinal muscular atrophy type of facioscapulohumeral disease.

Authors:  T Siddique; H Roper; M A Pericak-Vance; J Shaw; K L Warner; W Y Hung; K L Phillips; P Lunt; W J Cumming; A D Roses
Journal:  J Med Genet       Date:  1989-08       Impact factor: 6.318

5.  Exclusion mapping of chromosomal regions which cross hybridise to FSHD1A associated markers in FSHD1B.

Authors:  J R Gilbert; M C Speer; J Stajich; R Clancy; K Lewis; H Qiu; L Yamaoka; A Kumar; J Vance; C Stewart
Journal:  J Med Genet       Date:  1995-10       Impact factor: 6.318

6.  Evidence for heterogeneity in facioscapulohumeral muscular dystrophy (FSHD).

Authors:  J R Gilbert; J M Stajich; S Wall; S C Carter; H Qiu; J M Vance; C S Stewart; M C Speer; J Pufky; L H Yamaoka
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

7.  miRNA expression in control and FSHD fetal human muscle biopsies.

Authors:  Débora Morueco Portilho; Marcelo Ribeiro Alves; Gueorgui Kratassiouk; Stéphane Roche; Frédérique Magdinier; Eliane Corrêa de Santana; Anna Polesskaya; Annick Harel-Bellan; Vincent Mouly; Wilson Savino; Gillian Butler-Browne; Julie Dumonceaux
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

8.  Chromosome 4q35 haplotypes and DNA rearrangements segregating in affected subjects of 19 Italian families with facioscapulohumeral muscular dystrophy (FSHD).

Authors:  S Cacurri; G Deidda; N Piazzo; A Novelletto; I La Cesa; S Servidei; G Galluzzi; C Wijmenga; R R Frants; L Felicetti
Journal:  Hum Genet       Date:  1994-10       Impact factor: 4.132
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.